Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic review

BACKGROUND: Angiotensin-converting-enzyme-2, being the receptor for SARS-CoV-2, is increased in the use of RAAS inhibitors. Therefore, concerns have been raised over risks of SARS-CoV-2 infection and poor prognosis of COVID-19 in persons with prior exposure to these drugs. This study aimed to system...

Descripción completa

Detalles Bibliográficos
Autores principales: Iheanacho, Chinonyerem O., Odili, Valentine U., Eze, Uchenna I. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988641/
https://www.ncbi.nlm.nih.gov/pubmed/33778087
http://dx.doi.org/10.1186/s43094-021-00224-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988641/
https://www.ncbi.nlm.nih.gov/pubmed/33778087
http://dx.doi.org/10.1186/s43094-021-00224-4

Ejemplares similares